Pierre Fabre Medicament

NCT03887130

Phase 2, Completed, 2007, 152 people, 22 Mar 2019, clinicaltrials.gov

NCT02730091

Collaborator, Phase 3, Terminated, 2016, 98 people, 6 Apr 2016, clinicaltrials.gov

NCT02347332

Phase 3, Completed, 2014, 459 people, 27 Jan 2015, clinicaltrials.gov

NCT02054338

Phase 3, Terminated, 2006, 1,004 people, 4 Feb 2014, clinicaltrials.gov

NCT01916252

Collaborator, Phase 3, Completed, 2013, 460 people, 5 Aug 2013, clinicaltrials.gov

NCT01779258

Phase 3, Completed, 2013, 347 people, 30 Jan 2013, clinicaltrials.gov

NCT01599013

Phase 2, Completed, 2011, 69 people, 15 May 2012, clinicaltrials.gov

NCT01203228

Collaborator, Phase 3, Terminated, 2004, 129 people, 16 Sept 2010, clinicaltrials.gov

NCT00683514

Phase 3, Completed, 2005, 201 people, 23 May 2008, clinicaltrials.gov